These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2522246)

  • 1. Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on growth of primary meningioma cells in monolayer tissue culture.
    Waelti ER; Markwalder TM
    Surg Neurol; 1989 Feb; 31(2):96-100. PubMed ID: 2522246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonotherapy of meningiomas with medroxyprogesterone acetate. Immunohistochemical demonstration of the effect of medroxyprogesterone acetate on growth fractions of meningioma cells using the monoclonal antibody Ki-67.
    Markwalder TM; Gerber HA; Waelti E; Schaffner T; Markwalder RV
    Surg Neurol; 1988 Aug; 30(2):97-101. PubMed ID: 2969629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on receptor status of meningioma cytosols.
    Markwalder TM; Waelti E; König MP
    Surg Neurol; 1987 Jul; 28(1):3-9. PubMed ID: 2954242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse correlation of cell proliferation and expression of progesterone receptors in tumor spheroids and monolayer cultures of human meningiomas.
    Tonn JC; Ott MM; Bouterfa H; Kerkau S; Kapp M; Müller-Hermelink HK; Roosen K
    Neurosurgery; 1997 Nov; 41(5):1152-9. PubMed ID: 9361071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone treatment of meningiomas: lack of response to medroxyprogesterone acetate (MPA). A pilot study of five cases.
    Jääskeläinen J; Laasonen E; Kärkkäinen J; Haltia M; Troupp H
    Acta Neurochir (Wien); 1986; 80(1-2):35-41. PubMed ID: 2939693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway.
    Schrell UM; Rittig MG; Anders M; Kiesewetter F; Marschalek R; Koch UH; Fahlbusch R
    J Neurosurg; 1997 May; 86(5):845-52. PubMed ID: 9126901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo.
    Matsuda Y; Kawamoto K; Kiya K; Kurisu K; Sugiyama K; Uozumi T
    J Neurosurg; 1994 Mar; 80(3):527-34. PubMed ID: 8113866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma.
    Altinoz MA; Ozpinar A; Elmaci I
    Neurosurg Rev; 2019 Jun; 42(2):351-369. PubMed ID: 29453736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of meningioma cell growth by sex steroid hormones in vitro.
    Jay JR; MacLaughlin DT; Riley KR; Martuza RL
    J Neurosurg; 1985 May; 62(5):757-62. PubMed ID: 3989596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression.
    Korhonen K; Salminen T; Raitanen J; Auvinen A; Isola J; Haapasalo H
    J Neurooncol; 2006 Oct; 80(1):1-7. PubMed ID: 16703453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone receptors are detectable in tumor fragment spheroids of meningiomas in vitro.
    Tonn JC; Ott MM; Meixensberger J; Paulus W; Roosen K
    Anticancer Res; 1994; 14(6B):2453-6. PubMed ID: 7872666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature.
    Wolfsberger S; Doostkam S; Boecher-Schwarz HG; Roessler K; van Trotsenburg M; Hainfellner JA; Knosp E
    Neurosurg Rev; 2004 Oct; 27(4):238-45. PubMed ID: 15168138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor-4 is expressed in meningiomas and mediates the antiproliferative action of paclitaxel.
    Tichomirowa MA; Theodoropoulou M; Daly AF; Yassouridis A; Hansen S; Lu J; Lange M; Goldbrunner RH; Stalla GK; Renner U
    Int J Cancer; 2008 Oct; 123(8):1956-63. PubMed ID: 18688857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone and glucocorticoid receptor activation in meningiomas.
    Carroll RS; Zhang J; Dashner K; Black PM
    Neurosurgery; 1995 Jul; 37(1):92-7. PubMed ID: 8587697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal manipulation of meningiomas in vitro.
    Olson JJ; Beck DW; Schlechte J; Loh PM
    J Neurosurg; 1986 Jul; 65(1):99-107. PubMed ID: 3712034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningiomas, epidermal growth factor and progesterone.
    Koper JW; Lamberts SW
    Hum Reprod; 1994 Jun; 9 Suppl 1():190-4. PubMed ID: 7962464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mifepristone (RU 486) treatment of meningiomas.
    Lamberts SW; Tanghe HL; Avezaat CJ; Braakman R; Wijngaarde R; Koper JW; de Jong H
    J Neurol Neurosurg Psychiatry; 1992 Jun; 55(6):486-90. PubMed ID: 1619417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferation and progesterone receptor status in benign meningiomas are not age dependent.
    Roser F; Nakamura M; Ritz R; Bellinzona M; Dietz K; Samii M; Tatagiba MS
    Cancer; 2005 Aug; 104(3):598-601. PubMed ID: 15952201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningioma and hormonal influences.
    Wahab M; Al-Azzawi F
    Climacteric; 2003 Dec; 6(4):285-92. PubMed ID: 15006250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.